Who founded Lumos Pharma?

Lumos Pharma was founded by Richard John Hawkins in 2014.

Who are Lumos Pharma's investors?

Lumos Pharma's investors include New Enterprise Associates (NEA), Sante Health Ventures.

How much funding has Lumos Pharma raised?

Lumos Pharma has disclosed $47M raised across 2 rounds.

Where is Lumos Pharma headquartered?

Lumos Pharma is headquartered in Austin, US.

Lumos Pharma

Austin, US · Founded 2014 · Delaware corporation · 49 employees on LinkedIn · 2 known investors

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency. It also pursues partnerships to in-license or acquire additional rare disease therapeutic candidates for development and commercialization.

Biotech Healthtech

Founders & leadership

Lumos Pharma was founded in 2014 by Richard John Hawkins.

Richard John HawkinsFounder

John C. McKewPresident and Chief Scientific Officer

Pisit "Duke" PitukcheewanontChief Medical Officer

Lori LawleyChief Financial Officer

Brad PowersChief Compliance Officer and General Counsel

Campbell MurrayExecutive Chairman

Board

Kevin M. LalandeBoard director

Edward J. MathersBoard director

George Gilbert CloydBoard director

Robert HeftBoard director

Jon S. SaxeBoard director

Investors · 2

New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Sante Health VenturesreportedAustin

Reported raises · per SEC filings

Form D private placements

$47M disclosed across 2 rounds · 2014–2016

▶$34MraisedApr 2016 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Michele ParkDirector
G. Gilbert CloydDirector
Kevin LelandeDirector
Robert HeftDirector
Cameron WheelerDirector
Richard John HawkinsExecutive Officer, Director
Edward MathersDirector
Jon S. SaxeDirector
Tracy SaxtonDirector

Offering amount: $34M
Amount sold: $34M
First sale: Apr 2016
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$13MraisedMay 2015 · 5 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Kevin M. LalandeDirector
Richard John HawkinsExecutive Officer, Director
George Gilbert CloydDirector
Robert HeftDirector
Jon S. SaxeDirector
Edward J. MathersDirector

Offering amount: $13M
Amount sold: $13M
First sale: Jan 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Lumos Pharma do?: Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency. It also pursues partnerships to in-license or acquire additional rare disease therapeutic candidates for development and commercialization.
Who founded Lumos Pharma?: Lumos Pharma was founded by Richard John Hawkins in 2014.
Who are Lumos Pharma's investors?: Lumos Pharma's investors include New Enterprise Associates (NEA), Sante Health Ventures.
How much funding has Lumos Pharma raised?: Lumos Pharma has disclosed $47M raised across 2 rounds.
Where is Lumos Pharma headquartered?: Lumos Pharma is headquartered in Austin, US.